Dataset from A Randomized, Placebo Controlled, Double Blind, Parallel Group Multi-Center Study In Order To Investigate Safety And Efficacy Of CP- 690 550 In Subjects With Moderate To Severe Ulcerative Colitis.
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00006773
下载链接
链接失效反馈官方服务：
资源简介：
The hypothesis of the study is that at least one dose of CP 690 550 is superior to placebo
(inactive drug) in inducing remission in patients with moderate to severe ulcerative colitis.
本研究的假说为：在诱导中重度溃疡性结肠炎患者病情缓解方面，至少一剂CP 690 550的效果优于安慰剂（placebo，无活性药物）。
创建时间：
2025-02-25
